Singapore markets closed
Straits Times Index
3,313.48 +8.49 (+0.26%) Nikkei
38,787.38 -132.88 (-0.34%) Hang Seng
19,553.61 +177.08 (+0.91%) FTSE 100
8,420.26 -18.39 (-0.22%) Bitcoin USD
66,897.20 +1,462.37 (+2.23%) CMC Crypto 200
1,369.64 -4.20 (-0.31%)
ProKidney Corp. (PROK)
NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
Loading interactive chart…
- Simply Wall St.
We're Hopeful That ProKidney (NASDAQ:PROK) Will Use Its Cash Wisely
Just because a business does not make any money, does not mean that the stock will go down. For example, biotech and...
- GuruFocus.com
ProKidney Corp Reports First Quarter 2024 Financial Results
Performance Analysis and Future Outlook Amidst Ongoing Clinical Developments
- GlobeNewswire
ProKidney Reports Business Updates and First Quarter 2024 Financial Results
Final results from RMCL-002 Phase 2 trial to be presented in the Late Breaking Clinical Trials session at the European Renal Association (ERA) Congress on May 25, 2024. An investor call to provide a perspective on CKD with Dr. Arnold Silva and Dr. Steven Coca and a recap of the RMCL-002 data is planned for May 28, 2024On schedule to resume manufacturing and PROACT 1 Phase 3 trial, commence PROACT 2 Phase 3 trial, and readout interim results from the ongoing REGEN-007 Phase 2 trial in mid-2024Str
© 2024 Yahoo. All rights reserved.